Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Martinez

Showing results (521-530 of 600) with videos related to

Pageof 60
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-line treatment for patients with Undifferentiated Pleomorphic SarcomaJavier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge, et al.
Eclinicalmedicine|January 21, 2020
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.
Journal of Crohn'S & Colitis|January 21, 2016
Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's DiseaseCarlos Taxonera, Manuel Barreiro-de-Acosta, Guillermo Bastida, et al.
Plos Biology|December 6, 2011
Copy number variation of KIR genes influences HIV-1 controlKimberly Pelak, Anna C Need, Jacques Fellay, et al.
Frontiers in Oncology|August 21, 2023
TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neckJordi Rubió-Casadevall, Beatriz Cirauqui Cirauqui, Javier Martinez Trufero, et al.
The Journal of Experimental Medicine|April 7, 2004
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infectionRika Draenert, Sylvie Le Gall, Katja J Pfafferott, et al.
Oncotarget|May 1, 2018
Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patientsDavid S Moura, Rafael Ramos, Antonio Fernandez-Serra, et al.
Plos Pathogens|November 18, 2021
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adultsVinicius A Vieira, Emily Adland, David F G Malone, et al.
International Journal of Cardiology|May 27, 2014
Effect of ischemic postconditioning on microvascular obstruction in reperfused myocardial infarction. Results of a randomized study in patients and of an experimental model in swineVicente Bodi, Juan M Ruiz-Nodar, Eloisa Feliu, et al.
Med (New York, N.Y.)|October 16, 2024
Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressorsÁngel Bayón-Gil, Inmaculada Hernández, Judith Dalmau, et al.
Pageof 60

Showing results (521-530 of 600) with videos related to

Sort By:
Pageof 60
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-line treatment for patients with Undifferentiated Pleomorphic SarcomaJavier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge, et al.
Eclinicalmedicine|January 21, 2020
Corrigendum to 'Therapeutic vaccination refocuses T-cell responses towards conserved regions of HIV-1 in early treated individuals (BCN 01 study)' EClinicalMedicine 11 (2019) 65-80Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.
Journal of Crohn'S & Colitis|January 21, 2016
Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's DiseaseCarlos Taxonera, Manuel Barreiro-de-Acosta, Guillermo Bastida, et al.
Plos Biology|December 6, 2011
Copy number variation of KIR genes influences HIV-1 controlKimberly Pelak, Anna C Need, Jacques Fellay, et al.
Frontiers in Oncology|August 21, 2023
TTCC-2019-02: real-world evidence of first-line cetuximab plus paclitaxel in recurrent or metastatic squamous cell carcinoma of the head and neckJordi Rubió-Casadevall, Beatriz Cirauqui Cirauqui, Javier Martinez Trufero, et al.
The Journal of Experimental Medicine|April 7, 2004
Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infectionRika Draenert, Sylvie Le Gall, Katja J Pfafferott, et al.
Oncotarget|May 1, 2018
Gene expression analyses determine two different subpopulations in KIT-negative GIST-like (KNGL) patientsDavid S Moura, Rafael Ramos, Antonio Fernandez-Serra, et al.
Plos Pathogens|November 18, 2021
An HLA-I signature favouring KIR-educated Natural Killer cells mediates immune control of HIV in children and contrasts with the HLA-B-restricted CD8+ T-cell-mediated immune control in adultsVinicius A Vieira, Emily Adland, David F G Malone, et al.
International Journal of Cardiology|May 27, 2014
Effect of ischemic postconditioning on microvascular obstruction in reperfused myocardial infarction. Results of a randomized study in patients and of an experimental model in swineVicente Bodi, Juan M Ruiz-Nodar, Eloisa Feliu, et al.
Med (New York, N.Y.)|October 16, 2024
Host genetic and immune factors drive evasion of HIV-1 pathogenesis in viremic non-progressorsÁngel Bayón-Gil, Inmaculada Hernández, Judith Dalmau, et al.
Pageof 60